Skin substitutes

Israel Medical Association Journal

Volumn 8, Issue 3, 2006, Pages 188-191

  Bar Meir, Eran ^a,b   Mendes, David ^a   Winkler, Eyal ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b NONE   (Israel)

Author keywords

Burns; Skin replacements; Skin substitutes; Wounds

Indexed keywords

BURN; CELL CULTURE; CHRONIC WOUND; CLINICAL EFFECTIVENESS; COMPETENCE; COST EFFECTIVENESS ANALYSIS; HUMAN; KERATINOCYTE; REVIEW; SKIN GRAFT; SURVIVAL RATE; SYSTEMATIC REVIEW; WOUND CLOSURE;

BURNS; HUMANS; SKIN, ARTIFICIAL; WOUND HEALING;

EID: 33645468078     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Tavis MJ, Thornton JW, Bartlett RH, Roth JC, Woodroof EA. A new composite skin prosthesis. Burns 1980;7:123-30.
2. Smith DJ Jr, Robson MC, Meltzer T, Smith AA, McHugh TP, Heggers JP. DRG-driven change in burn wound management: a success story. Plast Reconstr Surg 1988;82(4):710-12.
3. Purdue GF, Hunt JL, Gillespie RW, et al. Biosynthetic skin substitute versus frozen human cadaver allograft for temporary coverage of excised burn wounds. J Trauma 1987;27(2):155-7.
4. Jones I, Currie L, Martin R. A guide to biological skin substitutes. Br J Plast Surg 2002;55(3):185-93.
5. Thivolet J, Faure M, Demidem A, Mauduit G. Long-term survival and immunological tolerance of human epidermal allografts produced in culture. Transplantation 1986;42(3):274-80.
6. Purdue GF, Hunt JL, Still JM Jr, et al. A multicenter clinical trial of a biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil 1997;18(1 Pt 1):52-7.
7. Spielvogel RL. A histological study of Dermagraft-TC in patients' burn wounds. J Burn Care Rehabil 1997;18(1 Pt 2):S16-18.
8. Noordenbos J, Hansbrough JF, Gutmacher H, Dore C, Hansbrough WB. Enteral nutritional support and wound excision and closure do not prevent postburn hypermetabolism as measured by continuous metabolic monitoring. J Trauma 000;49(4):667-71.
9. Demling RH, DeSanti L. Management of partial thickness facial burns (comparison of topical antibiotics and bio-engineered skin substitutes). Burns 1999;25(3):256-61.
10. Leigh IM, Purkis PE, Navsaria HA, Phillips TJ. Treatment of chronic venous ulcers with sheets of cultured allogenic keratinocytes. Br J Dermatol 1987;117(5):591-7.
11. De Luca M, Albanese E, Bondanza S, et al. Multicentre experience in the treatment of burns with autologous and allogenic cultured epithelium, fresh or preserved in a frozen state. Burns 1989;15(5):303-9.
12. Phillips TJ, Bhawan J, Leigh IM. Baum HJ, Gilchrest BA. Cultured epidermal autografts and allografts: a study of differentiation and allograft survival. J Am Acad Dermatol 1990;23(2 Pt 1):189-98.
13. Phillips TJ, Gilchrest BA. Cultured epidermal allografts as biological wound dressings. Prog Clin Biol Res 1991;365:77-94.
14. Falanga V, Margolis D, Alvarez O, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol 1998;134(3):293-300.
15. Hansbrough JF, Cooper ML, Cohen R, et al. Evaluation of a biodegradable matrix containing cultured human fibroblasts as a dermal replacement beneath meshed skin grafts on athymic mice. Surgery 1992;111(4):438-46.
16. Hansbrough JF, Morgan J, Greenleaf G, Underwood J. Development of a temporary living skin replacement composed of human neonatal fibroblasts cultured in Biobrane, a synthetic dressing material. Surgery 1994;115(5):633-44.
17. Allenet B, Paree F, Lebrun T, et al. Cost-effectiveness modeling of Dermagraft for the treatment of diabetic foot ulcers in the French context. Diabetes Metab 2000;26(2):125-32.
18. Naughton G, Mansbridge J, Gentzkow G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Organs 1997;21(11):1203-10.
19. Wainwright D, Madden M, Luterman A, et al. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J Burn Care Rehabil 1996;17(2):124-36.
20. Yannas IV, Burke JF, Gordon PL, Huang C, Rubenstein RH. Design of an artificial skin. II: Control of chemical composition. J Biomed Mater Res 1980;14(2):107-32.
21. Yannas IV, Burke JF. Design of an artificial skin. I: Basic design principles. J Biomed Mater Res 1980;14(1):65-81.
22. Heimbach D, Luterman A, Burke J, et al. Artificial dermis for major burns. A multi-center randomized clinical trial. Ann Surg 1988;208(3):313-20.
23. Grzesiak JJ, Pierschbacher MD, Amodeo MF, Malaney TI, Glass JR. Enhancement of cell interactions with collagen/glycosaminoglycan matrices by RGD derivatization. Biomaterials 1997;18(24):1625-32.
24. Matsuda K, Suzuki S, Isshiki N, et al. A bilayer "artificial skin" capable of sustained release of an antibiotic. Br J Plast Surg 1991;44(2):142-6.
25. Yannas IV, Lee E, Orgill DP, Skrabut EM, Murphy GF. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. Proc Natl Acad Sci USA 1989;86(3):933-7.
26. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975;6(3):331-43.
27. Odessey R. Addendum: Multicenter experience with cultured epidermal autograft for treatment of burns. J Burn Care Rehabil 1992;13(1):174-80.
28. Hunyadi J, Farkas B, Bertenyi C, Olah J, Dobozy A. Keratinocyte grafting: a new means of transplantation for full-thickness wounds. J Dermatol Surg Oncol 1988;14(1):75-8.
29. Lam PK, Chan ES, To EW, Lau CH, Yen SC, King WW. Development and evaluation of a new composite Laserskin graft. J Trauma 1999;47(5):918-22.
30. Navarro FA, Stoner ML, Park CS, et al. Sprayed keratinocyte suspensions accelerate epidermal coverage in a porcine microwound model. J Burn Care Rehabil 2000;21(6):513-18.